<article>Singapore and India-based private equity firm <a style="color: #000080;" href="http://quadriacapital.com/" target="_blank">Quadria Capital</a> said it had raised $304 million for healthcare investments in South and Southeast Asia.</article>

Singapore and India-based private equity firm <a style="color: #000080;" href="http://quadriacapital.com/" target="_blank">Quadria Capital</a> said it had raised $304 million for healthcare investments in South and Southeast Asia.
Quadria Capital, which is among Asia’s largest healthcare PE firms, raised this amount under its first sector focused fund &#8211; Quadria Capital Fund L.P.
The company said this fund had seen its final close, and it comes after nearly three years, since it had been launched.
Quadria said it would it would make equity investments in high quality and scalable mid-sized healthcare companies in South and South-east Asia, and added that the fund would target four key healthcare sub-sectors &#8211; healthcare delivery, life sciences, medical technology, and associated healthcare services.
The fund has already completed two investments &#8211; <a style="color: #000080;" href="http://www.medicahospitals.in/" target="_blank">Medica Synergie</a>, a hospital network in eastern India and and <a style="color: #000080;" href="http://sohoglobalhealth.com/" target="_blank">SOHO Global Health</a>, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia.
SOHO, which is based in Jakarta, develops, manufactures, and markets evidence based natural medicine, and over-the-counter products primarily for Indonesia. In 2013, SOHO set up a joint venture partnership with a leading multinational pharmaceutical business, <a style="color: #000080;" href="https://www.fresenius-kabi.com/" target="_blank">Fresenius Kabi</a>, principally for the production and sale of innovative pharmaceutical liquid injectable products, and branded generics.
Amit Varma, managing partner at Quadria Capital, said: &#8220;We are very pleased that several premier institutions with deep healthcare experience have entrusted their capital with us. This underscores their confidence in our knowledge and skills in assessing the sector and in sourcing deals with outperformance potential,&#8221; he said.
&#8220;There is rising demand in Asia for quality healthcare products and services, driven by an ageing population, affluence and changing disease patterns. We see exciting opportunities for Quadria Capital aswe position our Fund to serve the needs of the region for quality healthcare and our investors for exceptional returns,&#8221; he added.
The investors in its latest fund include the<a style="color: #000080;" href="http://www.ifc.org/" target="_blank"> International Finance Corporation</a> of the World Bank, government institutions from Europe and the Middle East as well as institutional investors and family offices.
Quadria Capital’s managing partner, Abrar Mir, said the firm was focussed on &#8220;producing superior returns for our investors and to make positive development impact on local communities&#8221;.
&#8220;We thank our investors who have been our partners since launch, and welcome our new investors. We remain focused and driven to achieve our mission of producing superior returns for our investors and to make positive developmental impact on local communities,&#8221; he added.
Also Read:
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/quadria-cap-invests-in-indonesian-pharma-co-soho-4040/">Quadria Cap invests in Indonesian pharma co SOHO</a>
<a style="color: #ff0000;" title="Navis acquires controlling stake in Dometic Medical" href="http://www.dealstreetasia.com/stories/navis-acquires-controlling-stake-dometic-medical-division-3358/" rel="bookmark">Navis acquires controlling stake in Dometic Medical</a>
<a style="color: #ff0000;" title="Vietnam’s Vinapharm &amp; 7 other pharma cos plan IPOs this year" href="http://www.dealstreetasia.com/stories/eight-vietnam-pharm-cos-plan-ipos-this-year-3431/" rel="bookmark">Vietnam’s Vinapharm &amp; 7 other pharma cos plan IPOs this year</a>

Quadria Capital said it had raised $304 million for healthcare investments in South and Southeast Asia.

Quadria Capital raises $304m for Asia healthcare investments

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Quadria Capital raises $304m for Asia healthcare investments

Start your deal-making journey now!

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief